Peter Friedmann, MD
Enriched profileAssociate Dean for Research and Professor of Medicine · UMass Chan Medical School
Peter Friedmann is Associate Dean for Research and Professor of Medicine at UMass Chan Medical School. OpenAlex indexes 303 publications with 14,011 citations (h-index 63); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Internal Medicine profiles in the FindMyKOL directory.
Data verified 13 Nov 2026
Overview
Updated 14 Nov 2026
Peter Friedmann, MD, is Associate Dean for Research and Professor of Medicine at UMass Chan Medical School. The public record shows 303 publications with 14,011 citations (h-index 63), centered on Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, HIV, Drug Use, Sexual Risk. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (2015–2023).
- Most recent indexed publication: 2025 · Addiction science & clinical practice
- Top research focus: Substance Abuse Treatment and Outcomes
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 14 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 7 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 189.
Clinical & industry
trials, payments and federal fundingContact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
3601 Main St. Room 327 Springfield, MA 01107
Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Assessing Optimal XRB Initiation Points in Jail
Sponsor: NYU Langone Health
- Rural New England Health Study (Phase 2)
Sponsor: Baystate Medical Center
Industry payments
Updated 13 Nov 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Indivior Inc.Program year202510 payments
NIH funding
Updated 13 Nov 2026
5 NIH research awards on record, funded 2015–2023 per NIH RePORTER. The latest:
- Assessing Optimal XR-Buprenorphine Initiation Points in Jail
New York University School of Medicine
FY2023$606,093R01DA056446 - Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center
Baystate Medical Center, Inc.
FY2023$593,679UG1DA050067 - Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center
Baystate Medical Center, Inc.
FY2022$2,073,692UG1DA050067
Congress activity
Updated 13 Nov 2026
3 congress contributions (2020–2022) across AACAP, AHA, IDSA per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 13 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genomic surveillance uncovers regional variation in HCV transmission networks in rural United States.
Nature communications
Article2025 - Medications for Opioid Use Disorder in County Jails - Outcomes after Release.
The New England journal of medicine
Article2025 - Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics?
Tropical medicine and infectious disease
Article2025
Most-cited works
by citation count (OpenAlex)- 01Patients’ use of the internet for medical informationArticle1,059 citations2002
- 02
- 03
- 04Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice OffendersArticle324 citations2016
- 05Does retention matter? Treatment duration and improvement in drug useArticle321 citations2003
Network
Updated 13 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
profiles.umassmed.edu/display/13847933
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Boston University School of Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗ - BA Medical Science
Boston University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗ - MD
MPH, DFASAM, FACP
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertwitnessprofiler.com ↗
Editorial & leadership roles
journal and society appointments- Chair
Advisory Board, C-DIAS
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →c-dias.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →c-dias.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy McAlindon, MD, MPH
UMass Chan Medical School
Jean Frazier, MD
UMass Chan Medical School
Anil Chandraker, MBChB
UMass Chan Medical School
Robert Zurier, MD
UMass Chan Medical School
Michael Matthay, MD
University of California San Francisco
Elaine Hylek, MD
Boston University Chobanian and Avedisian School of Medicine
Wilbert Aronow, MD
Westchester Medical Center
David Mannino, MD
University of Kentucky